In a new job - February 17, 2020
Oasmia appoints new CEO
The Board of Oasmia Pharmaceutical has appointed Francois Martelet as the new CEO. Martelet has extensive international experience of leading pharmaceutical companies. He replaces Sven Rohmann, who has been acting CEO during a crucial transition period. Rohmann remains in his position as Board member and will continue to play an active role in the company’s […]
In a new job - February 14, 2020
AroCell appoints Cecilia Ahlin as Chief Medical Officer
AroCell has announced that Cecilia Ahlin joins the management team as Chief Medical Officer. Cecilia Ahlin will lead and develop AroCell’s clinical strategy with focus on getting more clinical evidence for the use of TK1 as a biomarker in cancer treatment. Still an active oncologist treating patients Ahlin has over 20 years of experience treating […]
Uncategorized - February 12, 2020
The new life science centre Forskaren is taking shape
Vectura Fastigheter chooses 3XN Architects for Forskaren, in the new Stockholm district of Hagastaden, and begins collaboration with Sweden’s Science and Technology Museum. The selected entry by 3XN Architects was presented during a launch event on 30 January. The project includes producing the new life science centre, Forskaren, in the new Stockholm district of Hagastaden. […]
In a new job - February 5, 2020
She is the new CEO of Bactiguard
Christian Kinch resigns as CEO of Bactiguard and is proposed as new Chairman of the Board, and Cecilia Edström appointed new CEO. Christian Kinch has announced to the Board that he will resign as CEO of Bactiguard Holding after close to 16 years. The Board has appointed CFO and Deputy CEO Cecilia Edström as new […]
Uncategorized - January 21, 2020
Cheap drug may alleviate treatment-resistance in leukemia
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML), one of the most common forms of blood cancer. This is the conclusion of a study in mice and human blood cells performed at Karolinska Institutet and SciLifeLab and published in the medical journal EMBO Molecular Medicine. […]
In a new job - January 20, 2020
Frida Lawenius is SwedenBIO’s new Deputy Director General
Frida Lawenius has previously been responsible for strategic development and policy at Naturvetarna, the Swedish Association of Professional Scientists. “The entire value chain for life sciences is present within SwedenBIO and the industry’s success depends on that we connect the different parts of the chain. In order to create success, both when it comes to policy […]
